SynthesisBMC oral health2026
Efficacy of Leukocyte and Platelet-Rich Fibrin (L-PRF) as an adjunct to Open Flap Debridement (OFD) in periodontal intrabony defects: a systematic review and meta-analysis.
Synthesis in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeukocyte and platelet-rich fibrin (L-PRF) is an autologous biomaterial used in periodontal regenerative therapy due to its scaffold properties and sustained release of growth factors. This study aimed to evaluate the efficacy of L-PRF as an adjunct to open flap debridement (OFD) in the treatment of periodontal intrabony defects.
methodsIn accordance with PRISMA guidelines, a literature search of PubMed, Scopus, Web of Science and Cochrane CENTRAL was conducted up to November 2025 by two independent reviewers for randomized controlled trials (RCTs) evaluating L-PRF as an adjunct to OFD. Primary outcomes assessed were changes in probing depth (PD) and clinical attachment level (CAL); secondary outcomes included changes in radiographic bone fill (RBF) and gingival margin level (GML). Risk of bias and certainty of evidence were assessed using Cochrane RoB 2 and the GRADE approach, respectively. Pooled mean differences (MD) and 95% confidence intervals (CI) were calculated. Exploratory subgroup analyses evaluated lesion type, application protocols and centrifugation settings.
resultsTwenty-three RCTs were included. Twelve studies had low risk of bias, eight had some concerns and three had high risk. At 9 months (16 studies), L-PRF + OFD significantly improved PD (MD: 1.11 mm; 95% CI: 0.84-1.38) and CAL (MD: 1.13 mm; 95% CI: 0.79-1.48) compared with OFD alone (p < 0.05). Secondary outcomes (RBF and GML) also showed significant improvements. The certainty of evidence ranged from very low to moderate. Subgroup analyses suggested that defect morphology, application approach and centrifugation parameters may influence outcomes; however, these findings are exploratory and based on limited data.
conclusionsAdjunctive L-PRF appears to provide additional clinical and radiographic benefits in the management of periodontal intrabony defects when used as an adjunct to OFD. However, overall confidence in these findings is limited by very low to moderate certainty of evidence and substantial heterogeneity. Although outcomes may be influenced by defect characteristics and preparation protocols, current evidence does not support definitive clinical recommendations. Further well-designed, standardized multicenter RCTs with longer follow-up are required.
trial registrationPROSPERO registration number CRD42020168521.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.